FendX Technologies

FendX Technologies Current Liabilities

The Current Liabilities of FendX Technologies (FNDX.CN) as of Nov 1, 2026 is 1.00 M CAD. In the previous year, Current Liabilities was 802,336.00 CAD — a change of 24.73% (higher).

Current Liabilities

1.00 MCAD

YoY

24.73%

Last updated:

Current Liabilities of FendX Technologies is 2025 1.00 M CAD. Current Liabilities of FendX Technologies was 2024 802,336.00 CAD. It decreases by 24.73% higher compared to the previous year.

The FendX Technologies Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2020
330,000.00 CAD
Jan 1, 2021
387,590.00 CAD
Jan 1, 2022
830,337.00 CAD
Jan 1, 2023
519,752.00 CAD
Jan 1, 2024
802,336.00 CAD
Jan 1, 2025
1.00 M CAD
The FendX Technologies Current Liabilities history
YEARCurrent LiabilitiesYoY
1.00 MCAD+24.73%
802,336.00CAD+54.37%
519,752.00CAD-37.40%
830,337.00CAD+114.23%
387,590.00CAD+17.45%
330,000.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

FendX Technologies Stock analysis

What does FendX Technologies do? FendX Technologies, Inc. develops pathogen-repelling surface coatings, including the REPELWRAP film and a bifunctional spray nanotechnology. The REPELWRAP film prevents pathogen adhesion on surfaces, reducing transmission, while the spray repels and kills pathogens. The company collaborates with partners on R&D using its nanotechnology and holds a worldwide license from McMaster University for its IP portfolio covering both film and spray formulations. The firm focuses on products to reduce pathogen spread on contaminated surfaces. FendX Technologies, Inc. sells its film and spray products to customers seeking pathogen-repelling solutions for surfaces prone to contamination. The company's lead product, REPELWRAP film, is designed for protective surface coating applications. The bifunctional spray coating targets surfaces requiring both repelling and killing of pathogens. The firm's IP portfolio, licensed worldwide from McMaster University, supports its product development and commercialization. The company's business model centers on developing and commercializing pathogen-repelling surface coatings through its nanotechnology. REPELWRAP film and the bifunctional spray are the primary products under development. The firm's worldwide license from McMaster University for film and spray nanotechnology formulations enables its product offerings. FendX Technologies, Inc. generates revenue from the sale of these coatings to clients in sectors requiring surface contamination control. FendX Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about FendX Technologies stock

Current Liabilities of FendX Technologies is 1.00 M CAD in 2025.

Current Liabilities of FendX Technologies changed from 802,336.00 CAD to 1.00 M CAD, representing a 24.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities FendX Technologies since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's FendX Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — FendX Technologies

All Key Metrics — FendX Technologies